Condition

Classic Hodgkin Lymphoma clinical trials and research

• 8Clinical trials
• 3Countries

Newest Classic Hodgkin Lymphoma clinical trials

All recruiting trials (8)

• Bone density changes with anti-PD-1 immunotherapy

  This pilot will test if anti-PD-1 immunotherapy changes bone density in adults starting approved anti-PD-1 treatment for certain early-stage cancers.

  Recruiting Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07555210

• Pembrolizumab plus chemotherapy for frail adults with classical Hodgkin lymphoma who can't get standard treatment

  This phase II trial tests whether adding pembrolizumab to gemcitabine-based chemotherapy (with possible brentuximab vedotin and dacarbazine) helps frail adults newly diagnosed with classical Hodgkin lymphoma who are ineligible for standard anthracycline-based therapy.

  Recruiting Phase 2 City of Hope Medical Center · Duarte, California · NCT07275216

• ctDNA-guided therapy for relapsed or refractory Hodgkin lymphoma using pembrolizumab with GVD

  This study tests a pembrolizumab-based regimen plus chemotherapy in adults with relapsed or refractory classic Hodgkin lymphoma to see if ctDNA can guide treatment response and consolidation choices.

  Recruiting Phase 2 University of California, San Francisco · Davis, California and 5 other locations · NCT07021989

• Personalized chemotherapy reduction for advanced Hodgkin lymphoma

  This study is testing if people with advanced Hodgkin lymphoma can safely get fewer rounds of personalized chemotherapy based on their tumor DNA levels while still effectively treating their cancer.

  Recruiting at 6 sites Phase 2 University of Washington · Irvine, California and 5 other locations · NCT06745076

• Evaluating AK129 with or without AK117 for patients with resistant Classic Hodgkin Lymphoma

  This study is testing if a new treatment called AK129, alone or with another drug AK117, can help adults with tough-to-treat classic Hodgkin lymphoma feel better after other treatments have failed.

  Recruiting Phase 1/2 Akeso · Beijing · NCT06642792

• Combination of Pembrolizumab and BEAM for treating relapsed Hodgkin Lymphoma

  This study is testing if giving Pembrolizumab before and after a stem cell transplant can help people with relapsed Hodgkin Lymphoma feel better and have better outcomes.

  Recruiting Phase 2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT06377540

• Combining Pianzumab with AVD for treating advanced Hodgkin Lymphoma

  This study is testing if a new treatment combining penpulimab with the AVD regimen can help people with newly diagnosed advanced Hodgkin lymphoma feel better compared to standard treatments.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT05949931

• Examining blood cell growth patterns and heart health in Hodgkin lymphoma survivors

  This study is trying to see if certain blood cell changes in people who survived Hodgkin lymphoma can help us understand their heart health better and identify those at risk for heart problems.

  Recruiting at 35 sites Children's Oncology Group · Mobile, Alabama and 35 other locations · NCT05705531

Related topics

Quick answers

How many Classic Hodgkin Lymphoma clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (6 trials), China (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →